Supreme Secures Option To Procure Producing Medical Marijuana Facility

Supreme Pharmaceuticals Inc. (the “Company”) (OTCBB: SPRWF)(CSE: SL) is pleased to announce that after completion of its due diligence and the completion of other conditions, it has acquired the previously announced option with respect to the producing medical marijuana facility in the South Okanagan for $150,000.00 in cash and $100,000.00 in common shares of the Company at a deemed price of $0.05 per share, subject to regulatory approval.

About the Facility

The South Okanagan based facility has been in production since May of 2013. The current operator of the facility has successfully and cost effectively facilitated personal license holders’ production of monthly amounts of medical marijuana in full compliance with all regulatory authorities. The facility includes three green houses, a purpose-designed drying room, processing machinery, an office, and appropriate indoor equipment storage. All electrical, plumbing, security, and related plant and equipment are built to full commercial standards.

The philosophy of the current operator is “quality over quantity”. The facility strives to produce healthy, robust marijuana with high THC concentrations rather than significant quantities of a lesser quality product.

MMPR Application

The MMPR application is nearly complete and it is anticipated that it will be submitted by the end of April 2014. The application is for a production licence of 45 kilograms per month of medical marijuana to be produced in a significantly larger facility. There is no guarantee that the application for the MMPR licence will be successful.

To read more, visit http://markets.financialcontent.com/stocks/news/read/26987550/Supreme_Secures_Option_to_Purchase_Producing_Medical_Marijuana_Facility_

Posted in: News

Comments are closed.